Multiple sclerosis – Diagnostics

Go back

Diagnosing multiple sclerosis involves a careful combination of medical history, neurological examination, and specialized tests that help doctors identify damage to the central nervous system and rule out other conditions with similar symptoms.

Introduction: Who Should Seek Diagnostics and When

If you experience certain neurological symptoms that persist or appear suddenly, it may be time to seek medical evaluation for possible multiple sclerosis. People who should consider getting tested are those experiencing vision problems such as blurred vision, double vision, or eye pain, especially when these symptoms affect one eye at a time. Numbness or tingling sensations that affect one side of the face or body, or occur below the waist, are also important warning signs that deserve attention.[1][2]

Muscle weakness that typically appears on one side of the body or below the waist should prompt you to visit a doctor. Similarly, if you notice difficulties with balance, coordination, or walking that you cannot easily explain, these symptoms warrant medical investigation. Extreme fatigue that interferes with your daily activities, problems controlling your bladder or bowels, and difficulties with memory or concentration are additional reasons to seek evaluation.[3][4]

Multiple sclerosis typically begins in young adults, most commonly between the ages of 20 and 40 years old, though it can appear at any age. Women are about three times more likely to develop MS than men. Early diagnosis is particularly valuable because starting treatment early can help slow the disease’s progression and reduce the accumulation of disability over time.[2][3]

⚠️ Important
If you experience sudden weakness or numbness in one arm, sudden loss or blurring of vision, or sudden problems with balance and coordination, call emergency services immediately. These could be signs of a stroke and require urgent medical attention, even though they can also occur in MS.

Classic Diagnostic Methods for Multiple Sclerosis

Diagnosing multiple sclerosis is not straightforward because there is no single test that can definitively confirm the condition. Instead, doctors use a comprehensive approach that combines several different methods to build a complete picture. The diagnostic process begins with a thorough review of your medical history and a detailed neurological examination. Your physician will want to know about all your symptoms, when they started, how long they lasted, and whether they have come and gone over time.[4][6]

Medical History and Neurological Examination

During the initial consultation, your doctor will ask detailed questions about your symptoms and family medical history. They will want to know about any other medical conditions you have and what medications you are taking. This information helps them understand your overall health picture and identify any factors that might explain your symptoms or affect your treatment.[10]

The neurological examination is a hands-on assessment where your doctor tests various functions of your nervous system. They will check your reflexes by tapping certain areas of your body with a small hammer. They will observe how you walk and maintain your balance, which can reveal problems with coordination. Your doctor will also test the strength of different muscle groups throughout your body, examine your vision and eye movements, and assess sensation by touching different parts of your skin to see if you can feel normally. This examination helps identify any abnormalities that might indicate damage to the central nervous system, which includes your brain, spinal cord, and the nerves connecting your eyes to your brain.[6][10]

Blood Tests

While blood tests cannot directly diagnose multiple sclerosis, they play an important role in the diagnostic process by helping doctors rule out other conditions that can cause similar symptoms. Your healthcare team will take blood samples to check for infections, vitamin deficiencies (particularly vitamin B12), autoimmune disorders other than MS, and metabolic problems. These conditions can sometimes produce neurological symptoms that look like MS, so excluding them is an essential step toward an accurate diagnosis.[10][17]

Magnetic Resonance Imaging (MRI)

An MRI scan is one of the most valuable tools for diagnosing multiple sclerosis. This imaging test uses powerful magnets and radio waves to create detailed pictures of your brain and spinal cord. Unlike X-rays, MRI does not use radiation. The machine looks like a large tube, and you lie inside it while it takes images. The test is painless, though some people find the enclosed space uncomfortable and the machine can be quite noisy.[6][10]

The MRI can detect areas of damage in your brain and spinal cord called lesions or plaques. These are areas where the protective covering of nerve fibers, called myelin, has been damaged by the immune system’s attack. The lesions appear as bright spots on the MRI images and can be as small as a pinhead or as large as a golf ball. During the scan, doctors often inject a contrast dye into your vein to help highlight areas of active inflammation, making new or actively forming lesions more visible.[2][10]

The location, number, and characteristics of these lesions provide important clues about whether you have MS and what type it might be. However, having lesions on an MRI does not automatically mean you have MS, as other conditions can also cause similar changes in the brain and spinal cord.[6]

Lumbar Puncture (Spinal Tap)

A lumbar puncture, also called a spinal tap, involves collecting a small sample of the fluid that surrounds your brain and spinal cord. This fluid is called cerebrospinal fluid. During the procedure, you typically lie on your side with your knees drawn up toward your chest. The doctor cleans an area on your lower back and numbs it with local anesthetic. Then, they insert a thin needle between two bones in your lower spine to withdraw a small amount of fluid.[6][10]

Laboratory analysis of this fluid can reveal abnormalities commonly seen in people with MS. Specifically, doctors look for increased numbers of white blood cells and elevated levels of certain proteins, particularly oligoclonal bands. These bands are proteins produced by immune system cells and are found in the cerebrospinal fluid of most people with MS, but not in their blood. While finding these bands supports an MS diagnosis, their presence alone does not confirm it, and some people with MS do not have them.[10]

Evoked Potential Tests

Evoked potential tests measure how quickly and effectively electrical signals travel through your nervous system. These tests are particularly useful because they can detect damage to nerves even when that damage is not causing noticeable symptoms. There are different types of evoked potential tests, but the most common for MS diagnosis checks the nerves that carry visual information from your eyes to your brain.[6][10]

During a visual evoked potential test, you sit in front of a screen showing a changing checkerboard pattern while small electrodes placed on your scalp measure your brain’s electrical response. If the signals travel more slowly than normal, this suggests damage to the myelin covering the optic nerves. Similar tests can be done for the nerves that carry hearing and touch sensations. These tests are painless and simply involve watching or listening to stimuli while the machine records your brain’s responses.[10]

Optical Coherence Tomography (OCT)

Optical coherence tomography is a newer, noninvasive imaging technique that measures the thickness of specific layers at the back of your eye, particularly the retinal nerve fiber layers. This test is valuable for MS diagnosis because damage to myelin and the optic nerves, both indicators of the disease, can cause these layers to become thinner. The test works similarly to an ultrasound but uses light waves instead of sound waves to create detailed images. It is quick, painless, and provides information about nerve damage and degeneration associated with MS.[10]

Using the McDonald Criteria

Doctors use a set of guidelines called the McDonald Criteria to diagnose MS. These criteria were developed to standardize the diagnostic process and ensure accurate diagnosis. The criteria focus on finding evidence of damage that has occurred in different parts of the central nervous system (dissemination in space) and at different times (dissemination in time). This means doctors look for signs that MS has affected multiple areas of your nervous system and that these attacks or lesions have appeared at separate time points. Meeting these criteria through clinical symptoms and test results allows doctors to make a confident MS diagnosis.[11]

⚠️ Important
Some conditions can cause symptoms very similar to MS, such as neuromyelitis optica spectrum disorder and MOG-associated disorder, which are more common in people of Asian or African-American ethnicity. Your doctor may recommend additional blood tests to rule out these conditions and ensure you receive the correct diagnosis and treatment.

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to test new treatments for multiple sclerosis, they need to ensure that participants truly have the condition and meet specific criteria. This helps ensure that the study results are reliable and that the treatments being tested are evaluated fairly. The diagnostic tests used for clinical trial enrollment often mirror those used in standard clinical practice but may be applied with stricter standards and more frequent monitoring.[5]

MRI Monitoring in Clinical Trials

Magnetic resonance imaging plays a central role in clinical trial qualification and monitoring. Before enrolling in a trial, potential participants typically undergo detailed MRI scans of their brain and often their spinal cord. Researchers carefully count and measure existing lesions to establish a baseline. They look for evidence of recent disease activity, such as lesions that show enhancement with contrast dye, which indicates active inflammation. Throughout the trial, participants receive regular MRI scans at predetermined intervals to track whether new lesions appear or existing ones change.[8]

Clinical trials often use MRI activity as a key measure of whether a treatment is working. Researchers count the number of new lesions that form during the study and measure changes in the total volume of lesions. They also look for signs of brain shrinkage, called cortical atrophy, which can indicate disease progression. Modern clinical trials aim to find treatments that can prevent new lesions from forming, with some newer medications proving effective at preventing new lesions in up to 99 percent of patients in studies.[2][14]

Confirmation of MS Type and Disease Activity

Clinical trials typically enroll participants with specific types of MS. Researchers need to accurately classify whether someone has relapsing-remitting MS, secondary progressive MS, or primary progressive MS because treatments may work differently for each type. They review your medical history carefully, documenting all relapses you have experienced, how completely you recovered from them, and how your disability has progressed over time.[5][8]

Many trials require evidence of recent disease activity to qualify for participation. This might mean you have experienced a certain number of relapses within the past one or two years, or that your MRI scans show new or enlarging lesions. Some trials focus on people with very active or aggressive MS, while others may include people with less active disease or those who are in earlier stages of the condition.[11]

Disability Assessment Scales

Clinical trials use standardized scales to measure disability and track changes over time. The most common is the Expanded Disability Status Scale, though you may also encounter other assessment tools. These scales evaluate how well you can walk, use your hands, see, think, and perform daily activities. At the start of a trial, researchers carefully assess your disability level to establish a baseline. Throughout the study, they repeat these assessments at regular intervals to determine whether the treatment being tested helps prevent disability from worsening or even improves function.[5]

Laboratory Tests and Biomarkers

Before enrolling in a clinical trial, you will typically undergo comprehensive blood and urine testing. These tests serve multiple purposes. They confirm that you do not have other conditions that would make you ineligible for the trial. They establish baseline measurements of your organ function, particularly your liver and kidneys, which is important for monitoring any side effects from the experimental treatment. Some trials also look for specific biomarkers, which are measurable substances in your body that can indicate disease activity or predict how well you might respond to treatment.[5]

Some research studies examine cerebrospinal fluid obtained through lumbar puncture to look for specific proteins or antibodies that might serve as biomarkers. While standard clinical diagnosis might involve only one spinal tap, participation in certain research studies might require this procedure to be repeated at specific time points to monitor changes in these markers over time.[10]

Exclusion of Other Conditions

Clinical trials have strict eligibility criteria, and part of the qualification process involves ensuring you do not have other medical conditions that could interfere with the study. Researchers conduct thorough evaluations to rule out conditions that can mimic MS symptoms or that might make the experimental treatment unsafe for you. This might include testing for other autoimmune diseases, infections, cardiovascular problems, and other neurological disorders. Blood tests might specifically check for markers of conditions like neuromyelitis optica spectrum disorder or MOG-associated disorder, which can appear similar to MS but require different treatments.[17]

Treatment History Documentation

If you have already been taking medications for MS, clinical trial researchers will carefully document your treatment history. They need to know which disease-modifying therapies you have tried, how long you took them, and whether they were effective for you. Some trials are specifically designed for people who have not responded well to standard treatments, while others may only accept people who have never been treated before. In some cases, you may need to stop taking your current MS medication for a certain period before starting an experimental treatment in a trial, though this is always done with careful medical supervision.[8][9]

Prognosis and Survival Rate

Prognosis

The course of multiple sclerosis varies greatly from one person to another, making it difficult to predict exactly how the disease will affect any individual. Some people experience mild symptoms with little disability over their lifetime, while others face worsening symptoms that lead to increased disability over time. Most people with MS have a relapsing-remitting pattern at first, with short periods of symptoms that resolve fully or partially, followed by long stretches without noticeable symptoms. Over time, many people with relapsing-remitting MS eventually develop secondary progressive MS, where nerve damage accumulates and symptoms gradually worsen. About 10 to 15 percent of people have primary progressive MS from the beginning, with neurologic function worsening as soon as symptoms appear.[2][3][14]

The introduction of disease-modifying therapies has significantly improved the outlook for many people with MS, especially when treatment begins early. These medications can reduce the number and severity of relapses, slow disease progression, and prevent new lesions from forming. Advanced treatments available today can stop new lesion formation in approximately 99 percent of MS patients in clinical studies. With appropriate treatment and management, many people with MS can continue to work, maintain relationships, and enjoy activities they love. The disease does not define who they are; it is simply an extra challenge in their day-to-day life.[8][14]

Survival Rate

Multiple sclerosis is not considered a fatal disease, and most people with MS have a normal or near-normal life expectancy. A study found that people with MS lived to an average age of 75.9 years old, compared to 83.4 years for people without MS. Importantly, this gap has narrowed considerably over the past few decades as therapies have improved and MS can now be diagnosed and treated earlier, when treatment is most effective. People with MS are more vulnerable to certain complications that can affect health and longevity, including heart disease, pneumonia, pressure ulcers, and urinary tract infections. The risk of these complications varies depending on the severity and type of MS a person has. With proper medical care, symptom management, and attention to overall health, many people with MS live long, fulfilling lives.[2][14]

Ongoing Clinical Trials on Multiple sclerosis

  • Study on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway Sweden

References

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

https://www.ninds.nih.gov/health-information/disorders/multiple-sclerosis

https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis

https://www.nhs.uk/conditions/multiple-sclerosis/

https://www.ncbi.nlm.nih.gov/books/NBK499849/

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC7704606/

https://mymsaa.org/ms-information/treatments/introduction/

https://www.brighamandwomens.org/neurology/multiple-sclerosis-information/treatment

https://emedicine.medscape.com/article/1146199-treatment

https://www.ucsfhealth.org/education/living-with-multiple-sclerosis

https://www.webmd.com/multiple-sclerosis/living-with-multiple-sclerosis

https://www.houstonmethodist.org/blog/articles/2025/mar/living-well-with-ms-how-to-slow-progression-reduce-symptoms-of-multiple-sclerosis/

https://www.inovanewsroom.org/expert-commentary/2020/07/10-ways-to-live-better-with-multiple-sclerosis-part-three/

https://health.clevelandclinic.org/multiple-sclerosis-self-care

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://www.hackensackmeridianhealth.org/en/healthu/2025/01/15/lifestyle-tips-to-thrive-with-multiple-sclerosis

FAQ

Can multiple sclerosis be diagnosed with just one test?

No, there is no single test that can definitively diagnose multiple sclerosis. Doctors use a comprehensive approach combining medical history, neurological examination, MRI scans, blood tests, and sometimes lumbar puncture and evoked potential tests to build a complete picture and make an accurate diagnosis.

How long does it take to diagnose multiple sclerosis?

The time to diagnosis varies considerably from person to person. Some people receive a diagnosis quickly after their first symptoms, while others may experience symptoms for months or even years before receiving a definitive diagnosis. The diagnostic process depends on the pattern of symptoms, test results, and whether evidence of multiple attacks affecting different parts of the nervous system at different times can be documented.

Does having brain lesions on an MRI always mean I have MS?

No, having lesions visible on a brain MRI does not automatically mean you have multiple sclerosis. Other conditions can cause similar changes in the brain and spinal cord. This is why doctors use multiple diagnostic tests and carefully consider your medical history and symptoms before making an MS diagnosis. Blood tests help rule out conditions like infections, vitamin deficiencies, and other autoimmune disorders that can mimic MS.

Is a lumbar puncture (spinal tap) always necessary to diagnose MS?

Not always. While a lumbar puncture can provide valuable information supporting an MS diagnosis, particularly by detecting oligoclonal bands in cerebrospinal fluid, many people can be diagnosed based on their clinical symptoms and MRI findings alone. Your neurologist will determine whether a spinal tap is necessary based on your specific situation and how clear-cut the other diagnostic findings are.

What should I do if I think I might have MS symptoms?

If you experience symptoms such as vision problems, numbness or tingling, muscle weakness, balance difficulties, extreme fatigue, or bladder problems that persist or come and go, schedule an appointment with your doctor. While these symptoms are common and can be caused by many different conditions, it is important to get them checked. If you experience sudden weakness or numbness in one arm, sudden vision loss, or sudden balance problems, seek emergency care immediately as these could indicate a stroke.

🎯 Key Takeaways

  • Multiple sclerosis cannot be diagnosed with a single test; doctors combine medical history, neurological exams, MRI scans, blood tests, and sometimes spinal taps to reach an accurate diagnosis.
  • Early diagnosis and treatment of MS can significantly slow disease progression and reduce disability accumulation over time, making it crucial to seek medical attention when symptoms appear.
  • MRI scans detect lesions in the brain and spinal cord that indicate myelin damage, and these lesions can range from pinhead-sized to golf ball-sized areas of scarring.
  • Blood tests play an essential role in MS diagnosis by ruling out other conditions that mimic MS symptoms, such as infections, vitamin deficiencies, and other autoimmune disorders.
  • Clinical trials require comprehensive diagnostic evaluations including regular MRI monitoring, disability assessments, and documentation of disease activity to ensure participants meet eligibility criteria.
  • Most people with MS have a near-normal life expectancy, with modern treatments significantly improving outcomes compared to even a few decades ago.
  • The McDonald Criteria help doctors standardize MS diagnosis by looking for evidence of damage in different parts of the nervous system occurring at different times.
  • Some conditions like neuromyelitis optica spectrum disorder can appear very similar to MS but require different treatments, making accurate diagnosis critically important.